β-arrestin 2 (βarr2) regulates this via extracellular Signal-Regulated Kinase 1 and 2 (ERK1/2) phosphorylation and nuclear factor kappa B (NF-κB) activation in mice, suggesting potential therapeutic targets in rosacea (47). Here, MAPK3 is linked to rosacea.